EP2252289
COMBINATION THERAPY COMPRISING SGLT INHIBITORS AND DPP4 INHIBITORS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
16.1.2009EP published:
23.10.2019EP application number:
09701670.3
EPO information:
European Patent Register
Max expiry date:
15.1.2029
Title:
COMBINATION THERAPY COMPRISING SGLT INHIBITORS AND DPP4 INHIBITORS
Timeline
Today
16.1.2009EP application
23.10.2019EP Publication
Owner
Name:
Mitsubishi Tanabe Pharma CorporationAddress:
3-2-10, Dosho-machi, Chuo-ku Osaka-shi, 541-8505, Osaka, JP
Inventor
Name:
UETA, KiichiroAddress:
Osaka, JP
Name:
ARAKAWA, KenjiAddress:
Osaka, JP
Name:
MATSUSHITA, YasuakiAddress:
Osaka, JP
Priority
Number:
2177708 PDate:
17.1.2008Country:
US
Classification
Categories:
A61K 31/401, A61K 31/7004, A61K 31/7008, A61K 45/06, A61P 3/10